The Rs 475.48-crore IPO received bids for 1,30,39,277 shares against 97,50,482 shares on offer. The non-institutional investors led the demand with 1.8 times subscription, followed by retail investors with 1.32 times subscription.
In the grey market, the Sahajanand Medical Technologies shares were commanding a premium of 8 percent on the morning of October 19, as per InvestorGain. However, grey market premiums are unofficial indicators based on speculative trading and do not guarantee listing gains.
Ahead of the issue opening, the company mobilised 140.06 crore through anchor investors. Sahajanand Medical Technologies allotted 40.71 lakh equity shares to eight institutional investors through the anchor book on October 14 at the upper end of the price band.
Of the total allocation, 30.25 lakh shares, worth approximately Rs 104 crore, were allotted to five domestic mutual fund houses: Nippon Life India, DSP Mutual Fund, WhiteOak Capital, Invesco India, and UTI AMC. These investors participated through a total of seven schemes.
Allianz Global Investors Fund, Tata AIA Life Insurance Company, and Natixis International Funds were among the other participants in the anchor book.